Skip to content

Study on the Sedative Mode of Retention of Tracheal Intubation after Repair of Forearm Flap in Oral Cancer

Study on the Sedative Mode of Retention of Tracheal Intubation after Repair of Forearm Flap in Oral Cancer

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013199
Enrollment
Unknown
Registered
2017-11-01
Start date
2016-06-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral cancer

Interventions

Group A:midazolam combined with hydromorphone
GroupB:propol combined with hydromorphone
GroupC:dexmedetomidine combined with hydromorphone

Sponsors

Stomatology Hospital, Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Sixty patients with oral cancer were selected with elective surgery from June 2016 to June 2017, including male and female aged 18 to 80 years, weighing from 40 to 90 Kg, ASA grade I or II. They were performed radical surgeries, including primary enlargement resection, cervical lymphadenectomy, repair of oral and maxillofacial tissue defects by forearm flap, postoperative retention of tracheal intubation into ICU. ;Inclusion criteria: Sixty patients with oral cancer were selected with elective surgery from June 2016 to June 2017, including male and female aged 18 to 80 years, weighing from 40 to 90 Kg, ASA grade I or II. They were performed radical surgeries, including primary enlargement resection, cervical lymphadenectomy, repair of oral and maxillofacial tissue defects by forearm flap, postoperative retention of tracheal intubation into ICU. ;Inclusion criteria: Sixty patients with oral cancer were selected with elective surgery from June 2016 to June 2017, including male and female aged 18 to 80 years, weighing from 40 to 90 Kg, ASA grade I or II. They were performed radical surgeries, including primary enlargement resection, cervical lymphadenectomy, repair of oral and maxillofacial tissue defects by forearm flap, postoperative retention of tracheal intubation into ICU. ;Inclusion criteria: Sixty patients with oral cancer were selected with elective surgery from June 2016 to June 2017, including male and female aged 18 to 80 years, weighing from 40 to 90 Kg, ASA grade I or II. They were performed radical surgeries, including primary enlargement resection, cervical lymphadenectomy, repair of oral and maxillofacial tissue defects by forearm flap, postoperative retention of tracheal intubation into ICU. ;Inclusion criteria: Sixty patients with oral cancer were selected with elective surgery from June 2016 to June 2017, including male and female aged 18 to 80 years, weighing from 40 to 90 Kg, ASA grade I or II. They were performed radical surgeries, including primary enlargement resection, cervical lymphadenectomy, repair of oral and maxillofacial tissue defects by forearm flap, postoperative retention of tracheal intubation into ICU.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal nervous system or disease such as severe central nervous system or tumors or who have undergone intracranial surger; 2. patients with severe diabetes, high blood sugar, and overweight; 3. pregnant and lactating female patients; 4. patients with severe liver and kidney dysfunction; 5. patients with long term use of Benzodiazepines and morphine-derivative drugs; 6. patients with allergies to dexmedetomidine and propofol. ;Exclusion criteria: 1. Patients with abnormal nervous system or disease such as severe central nervous system or tumors or who have undergone intracranial surger; 2. patients with severe diabetes, high blood sugar, and overweight; 3. pregnant and lactating female patients; 4. patients with severe liver and kidney dysfunction; 5. patients with long term use of Benzodiazepines and morphine-derivative drugs; 6. patients with allergies to dexmedetomidine and propofol. ;Exclusion criteria: 1. Patients with abnormal nervous system or disease such as severe central nervous system or tumors or who have undergone intracranial surger; 2. patients with severe diabetes, high blood sugar, and overweight; 3. pregnant and lactating female patients; 4. patients with severe liver and kidney dysfunction; 5. patients with long term use of Benzodiazepines and morphine-derivative drugs; 6. patients with allergies to dexmedetomidine and propofol. ;Exclusion criteria: 1. Patients with abnormal nervous system or disease such as severe central nervous system or tumors or who have undergone intracranial surger; 2. patients with severe diabetes, high blood sugar, and overweight; 3. pregnant and lactating female patients; 4. patients with severe liver and kidney dysfunction; 5. patients with long term use of Benzodiazepines and morphine-derivative drugs; 6. patients with allergies to dexmedetomidine and propofol. ;Exclusion criteria: 1. Patients with abnormal nervous system or disease such as severe central nervous system or tumors or who have undergone intracranial surger; 2. patients with severe diabetes, high blood sugar, and overweight; 3. pregnant and lactating female patients; 4. patients with severe liver and kidney dysfunction; 5. patients with long term use of Benzodiazepines and morphine-derivative drugs; 6. patients with allergies to dexmedetomidine and propofol.

Design outcomes

Primary

MeasureTime frame
RamsayScore;TNF- a;IL - 6;

Countries

China

Contacts

Public ContactWang Li;Wang Li;Wang Li;Wang Li;Wang Li ;;;;

Stomatology Hospital, Wuhan University;Stomatology Hospital, Wuhan University;Stomatology Hospital, Wuhan University;Stomatology Hospital, Wuhan University;Stomatology Hospital, Wuhan University

WLi201608@163.com;WLi201608@163.com;WLi201608@163.com;WLi201608@163.com;WLi201608@163.com+86 18571715252;+86 18571715252;+86 18571715252;+86 18571715252;+86 18571715252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026